Microparticles provide a novel biomarker to predict severe clinical outcomes of dengue virus infection

Journal of Virology

Volumn 89, Issue 3, 2015, Pages 1587-1607

  Punyadee, Nuntaya ^a   Mairiang, Dumrong ^a,b   Thiemmeca, Somchai ^a   Komoltri, Chulaluk ^a   Pan ngum, Wirichada ^c   Chomanee, Nusara ^a   Charngkaew, Komgrid ^a   Tangthawornchaikul, Nattaya ^a,b   Limpitikul, Wannee ^d   Vasanawathana, Sirijitt ^e   Malasit, Prida ^a,b   Avirutnan, Panisadee ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d Songkhla Hospital   (Thailand)

^e KHON KAEN HOSPITAL   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CD19 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; FIBRINOGEN RECEPTOR; NONSTRUCTURAL PROTEIN 1; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BLEEDING TENDENCY; CELL ISOLATION; CELL VACUOLE; CHILD; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DISEASE SEVERITY; ERYTHROCYTE; ERYTHROCYTE COUNT; FEMALE; GENE IDENTIFICATION; HUMAN; HUMAN CELL; MALE; MEGAKARYOCYTE; MICROPARTICLE; MONONUCLEAR CELL; MUCOSAL BLEEDING; OPSONIZATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; REVERSE TRANSCRIPTION; THROMBOCYTE; THROMBOCYTE COUNT; TRANSMISSION ELECTRON MICROSCOPY; VIRUS PARTICLE; VIRUS SHEDDING; ADULT; ANIMAL; BLOOD; CHEMISTRY; MEMBRANE MICROPARTICLE; METABOLISM; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS;

DENGUE VIRUS;

ADULT; ANIMALS; APOPTOSIS; BIOMARKERS; CELL-DERIVED MICROPARTICLES; CHILD; CHILD, PRESCHOOL; DENGUE; FEMALE; HUMANS; MALE; PROGNOSIS; VIRAL ENVELOPE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84921466925     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02207-14     Document Type: Article

References (84)

1. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI. 2013. The global distribution and burden of dengue. Nature 496:504-507. http://dx.doi.org/10.1038/nature12060.
2. World Health Organization. 1997. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. World Health Organization, Geneva, Switzerland.
3. Nimmannitya S. 1987. Clinical spectrum and management of dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health 18:392-397.
4. Piccin A, Murphy WG, Smith OP. 2007. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 21:157-171. http://dx.doi.org/10.1016/j.blre.2006.09.001.
5. Berckmans RJ, Nieuwland R, Boing AN, Romijn FP, Hack CE, Sturk A. 2001. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 85:639-646.
6. Nieuwland R, Berckmans RJ, McGregor S, Boing AN, Romijn FP, Westendorp RG, Hack CE, Sturk A. 2000. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 95:930-935.
7. Aupeix K, Hugel B, Martin T, Bischoff P, Lill H, Pasquali JL, Freyssinet JM. 1997. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest 99:1546-1554. http://dx.doi.org/10.1172/JCI119317.
8. Combes V, Taylor TE, Juhan-Vague I, Mege JL, Mwenechanya J, Tembo M, Grau GE, Molyneux ME. 2004. Circulating endothelial microparticles in Malawian children with severe falciparum malaria complicated with coma. JAMA 291:2542-2544. http://dx.doi.org/10.1001/jama.291.21.2542-b.
9. Nantakomol D, Dondorp AM, Krudsood S, Udomsangpetch R, Pattanapanyasat K, Combes V, Grau GE, White NJ, Viriyavejakul P, Day NP, Chotivanich K. 2011. Circulating red cell-derived microparticles in human malaria. J Infect Dis 203:700-706. http://dx.doi.org/10.1093/infdis/jiq104.
10. Kornek M, Popov Y, Libermann TA, Afdhal NH, Schuppan D. 2011. Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells. Hepatology 53:230-242. http://dx.doi.org/10.1002/hep.23999.
11. Burger D, Schock S, Thompson CS, Montezano AC, Hakim AM, Touyz RM. 2013. Microparticles: biomarkers and beyond. Clin Sci (Lond) 124:423-441. http://dx.doi.org/10.1042/CS20120309.
12. Marin V, Kaplanski G, Gres S, Farnarier C, Bongrand P. 2001. Endothelial cell culture: protocol to obtain and cultivate human umbilical endothelial cells. J Immunol Methods 254:183-190. http://dx.doi.org/10.1016/S0022-1759(01)00408-2.
13. Puttikhunt C, Kasinrerk W, Srisa-ad, Duangchinda ST, Silakate W, Moonsom S, Sittisombut N, Malasit P. 2003. Production of anti-dengue NS1 monoclonal antibodies by DNA immunization. J Virol Methods 109:55-61. http://dx.doi.org/10.1016/S0166-0934(03)00045-4.
14. Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ. 1999. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94:3791-3799.
15. Bhakdi SC, Ottinger A, Somsri S, Sratongno P, Pannadaporn P, Chimma P, Malasit P, Pattanapanyasat K, Neumann HP. 2010. Optimized high gradient magnetic separation for isolation of Plasmodiuminfected red blood cells. Malar J 9:38. http://dx.doi.org/10.1186/1475-2875-9-38.
16. Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, Auethavornanan K, Jairungsri A, Kanlaya R, Tangthawornchaikul N, Puttikhunt C, Pattanakitsakul SN, Yenchitsomanus PT, Mongkolsapaya J, Kasinrerk W, Sittisombut N, Husmann M, Blettner M, Vasanawathana S, Bhakdi S, Malasit P. 2006. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis 193:1078-1088. http://dx.doi.org/10.1086/500949.
17. Lachmann PJ, Oldroyd RG, Milstein C, Wright BW. 1980. Three rat monoclonal antibodies to human C3. Immunology 41:503-515.
18. Innis BL, Nisalak A, Nimmannitya S, Kusalerdchariya S, Chongswasdi V, Suntayakorn S, Puttisri P, Hoke CH. 1989. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg 40:418-427.
19. Yenchitsomanus PT, Sricharoen P, Jaruthasana I, Pattanakitsakul SN, Nitayaphan S, Mongkolsapaya J, Malasit P. 1996. Rapid detection and identification of dengue viruses by polymerase chain reaction (PCR). Southeast Asian J Trop Med Public Health 27:228-236.
20. Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husmann M. 1998. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol 161:6338-6346.
21. Thongtan T, Panyim S, Smith DR. 2004. Apoptosis in dengue virus infected liver cell lines HepG2 and Hep3B. J Med Virol 72:436-444. http://dx.doi.org/10.1002/jmv.20004.
22. Meertens L, Carnec X, Lecoin MP, Ramdasi R, Guivel-Benhassine F, Lew E, Lemke G, Schwartz O, Amara A. 2012. The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe 12:544-557. http://dx.doi.org/10.1016/j.chom.2012.08.009.
23. Zhang X, Sheng J, Plevka P, Kuhn RJ, Diamond MS, Rossmann MG. 2013. Dengue structure differs at the temperatures of its human and mosquito hosts. Proc Natl Acad Sci U S A 110:6795-6799. http://dx.doi.org/10.1073/pnas.1304300110.
24. Ng ML, Corner LC. 1989. Detection of some dengue-2 virus antigens in infected cells using immuno-microscopy. Arch Virol 104:197-208. http://dx.doi.org/10.1007/BF01315543.
25. Winkler G, Maxwell SE, Ruemmler C, Stollar V. 1989. Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization. Virology 171:302-305. http://dx.doi.org/10.1016/0042-6822(89)90544-8.
26. Jacobs MG, Robinson PJ, Bletchly C, Mackenzie JM, Young PR. 2000. Dengue virus nonstructural protein 1 is expressed in a glycosylphosphatidylinositol-linked form that is capable of signal transduction. FASEB J 14:1603-1610. http://dx.doi.org/10.1096/fj.14.11.1603.
27. Noisakran S, Dechtawewat T, Avirutnan P, Kinoshita T, Siripanyaphinyo U, Puttikhunt C, Kasinrerk W, Malasit P, Sittisombut N. 2008. Association of dengue virus NS1 protein with lipid rafts. J Gen Virol 89:2492-2500. http://dx.doi.org/10.1099/vir.0.83620-0.
28. Avirutnan P, Zhang L, Punyadee N, Manuyakorn A, Puttikhunt C, Kasinrerk W, Malasit P, Atkinson JP, Diamond MS. 2007. Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. PLoS Pathog 3:e183. http://dx.doi.org/10.1371/journal.ppat.0030183.
29. Halstead SB, O'Rourke EJ. 1977. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med 146:201-217.
30. King AD, Nisalak A, Kalayanrooj S, Myint KS, Pattanapanyasat K, Nimmannitya S, Innis BL. 1999. B cells are the principal circulating mononuclear cells infected by dengue virus. Southeast Asian J Trop Med Public Health 30:718-728.
31. Davies KA, Hird V, Stewart S, Sivolapenko GB, Jose P, Epenetos AA, Walport MJ. 1990. A study of in vivo immune complex formation and clearance in man. J Immunol 144:4613-4620.
32. Schifferli JA, Ng YC, Peters DK. 1986. The role of complement and its receptor in the elimination of immune complexes. NEngl J Med 315:488-495. http://dx.doi.org/10.1056/NEJM198608213150805.
33. Malasit P. 1987. Complement and dengue haemorrhagic fever/shock syndrome. Southeast Asian J Trop Med Public Health 18:316-320.
34. Theofilopoulos AN, Wilson CB, Dixon FJ. 1976. The Raji cell radioimmune assay for detecting immune complexes in human sera. J Clin Invest 57:169-182. http://dx.doi.org/10.1172/JCI108257.
35. Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S, Vaughn DW, Nisalak A, Ennis FA, Rothman AL. 2002. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis 186:1165-1168. http://dx.doi.org/10.1086/343813.
36. Koraka P, Suharti C, Setiati TE, Mairuhu AT, Van Gorp E, Hack CE, Juffrie M, Sutaryo J, Van Der Meer GM, Groen J, Osterhaus AD. 2001. Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection. J Clin Microbiol 39:4332-4338. http://dx.doi.org/10.1128/JCM.39.12.4332-4338.2001.
37. Shu PY, Chen LK, Chang SF, Yueh YY, Chow L, Chien LJ, Chin C, Lin TH, Huang JH. 2000. Dengue NS1-specific antibody responses: isotype distribution and serotyping in patients with dengue fever and dengue hemorrhagic fever. J Med Virol 62:224-232. http://dx.doi.org/10.1002/1096-9071(200010)62:2<224::AID-JMV14>3.0.CO;2-C.
38. Nickells M, Hauhart R, Krych M, Subramanian VB, Geoghegan-Barek K, Marsh HC, Jr, Atkinson JP. 1998. Mapping epitopes for 20 monoclonal antibodies to CR1. Clin Exp Immunol 112:27-33. http://dx.doi.org/10.1046/j.1365-2249.1998.00549.x.
39. Chuansumrit A, Chaiyaratana W. 2014. Hemostatic derangement in dengue hemorrhagic fever. Thromb Res 133:10-16. http://dx.doi.org/10.1016/j.thromres.2013.09.028.
40. Orsi FA, Angerami RN, Mazetto BM, Quaino SK, Santiago-Bassora F, Castro V, de Paula EV, Annichino-Bizzacchi JM. 2013. Reduced thrombin formation and excessive fibrinolysis are associated with bleeding complications in patients with dengue fever: a case-control study comparing dengue fever patients with and without bleeding manifestations. BMC Infect Dis 13:350. http://dx.doi.org/10.1186/1471-2334-13-350.
41. Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV, Ataullakhanov FI. 2007. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 97:425-434. http://dx.doi.org/10.1160/TH06-06-0313.
42. Key NS, Kwaan HC. 2010. Microparticles in thrombosis and hemostasis. Semin Thromb Hemost 36:805-806. http://dx.doi.org/10.1055/s-0030-1267033.
43. Aye KS, Charngkaew K, Win N, Wai KZ, Moe K, Punyadee N, Thiemmeca S, Suttitheptumrong A, Sukpanichnant S, Prida M, Halstead SB. 2014. Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar. Hum Pathol 45:1221-1233. http://dx.doi.org/10.1016/j.humpath.2014.01.022.
44. Bargeron Clark K, Hsiao HM, Noisakran S, Tsai JJ, Perng GC. 2012. Role of microparticles in dengue virus infection and its impact on medical intervention strategies. Yale J Biol Med 85:3-18.
45. Kadiu I, Narayanasamy P, Dash PK, Zhang W, Gendelman HE. 2012. Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages. J Immunol 189:744-754. http://dx.doi.org/10.4049/jimmunol.1102244.
46. Dargan DJ, Subak-Sharpe JH. 1997. The effect of herpes simplex virus type 1 L-particles on virus entry, replication, and the infectivity of naked herpesvirus DNA. Virology 239:378-388. http://dx.doi.org/10.1006/viro.1997.8893.
47. Mack M, Kleinschmidt A, Bruhl H, Klier C, Nelson PJ, Cihak J, Plachy J, Stangassinger M, Erfle V, Schlondorff D. 2000. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med 6:769-775. http://dx.doi.org/10.1038/77498.
48. Hottz ED, Oliveira MF, Nunes PC, Nogueira RM, Valls-de-Souza R, Da Poian AT, Weyrich AS, Zimmerman GA, Bozza PT, Bozza FA. 2013. Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases. J Thromb Haemost 11:951-962. http://dx.doi.org/10.1111/jth.12178.
49. Alonzo MT, Lacuesta TL, Dimaano EM, Kurosu T, Suarez LA, Mapua CA, Akeda Y, Matias RR, Kuter DJ, Nagata S, Natividad FF, Oishi K. 2012. Platelet apoptosis and apoptotic platelet clearance by macrophages in secondary dengue virus infections. J Infect Dis 205:1321-1329. http://dx.doi.org/10.1093/infdis/jis180.
50. Noisakran S, Onlamoon N, Pattanapanyasat K, Hsiao HM, Songprakhon P, Angkasekwinai N, Chokephaibulkit K, Villinger F, Ansari AA, Perng GC. 2012. Role of CD61+ cells in thrombocytopenia of dengue patients. Int J Hematol 96:600-610. http://dx.doi.org/10.1007/s12185-012-1175-x.
51. Wang S, He R, Patarapotikul J, Innis BL, Anderson R. 1995. Antibodyenhanced binding of dengue-2 virus to human platelets. Virology 213:254-257. http://dx.doi.org/10.1006/viro.1995.1567.
52. Hottz ED, Lopes JF, Freitas C, Valls-de-Souza R, Oliveira MF, Bozza MT, Da Poian AT, Weyrich AS, Zimmerman GA, Bozza FA, Bozza PT. 2013. Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. Blood 122:3405-3414. http://dx.doi.org/10.1182/blood-2013-05-504449.
53. Nielsen MH, Beck-Nielsen H, Andersen MN, Handberg A. 2014. A flow cytometric method for characterization of circulating cell-derived microparticles in plasma. J Extracell Vesicles 3:20795. http://dx.doi.org/10.3402/jev.v3.20795.
54. Lacroix R, Dignat-George F. 2012. Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation. Thromb Res 129(Suppl 2):S27-S29. http://dx.doi.org/10.1016/j.thromres.2012.02.025.
55. Owens AP, III, Mackman N. 2011. Microparticles in hemostasis and thrombosis. Circ Res 108:1284-1297. http://dx.doi.org/10.1161/CIRCRESAHA.110.233056.
56. Siljander PR. 2011. Platelet-derived microparticles-an updated perspective. Thromb Res 127(Suppl 2):S30-S33. http://dx.doi.org/10.1016/S0049-3848(10)70152-3.
57. Ay C, Freyssinet JM, Sailer T, Vormittag R, Pabinger I. 2009. Circulating procoagulant microparticles in patients with venous thromboembolism. Thromb Res 123:724-726. http://dx.doi.org/10.1016/j.thromres.2008.09.005.
58. Shantsila E, Kamphuisen PW, Lip GY. 2010. Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. J Thromb Haemost 8:2358-2368. http://dx.doi.org/10.1111/j.1538-7836.2010.04007.x.
59. Toti F, Satta N, Fressinaud E, Meyer D, Freyssinet JM. 1996. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood 87:1409-1415.
60. Castaman G, Yu-Feng L, Battistin E, Rodeghiero F. 1997. Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation. Br J Haematol 96:458-463. http://dx.doi.org/10.1046/j.1365-2141.1997.d01-2072.x.
61. Taylor RP, Ferguson PJ, Martin EN, Cooke J, Greene KL, Grinspun K, Guttman M, Kuhn S. 1997. Immune complexes bound to the primate erythrocyte complement receptor (CR1) via anti-CR1 mAbs are cleared simultaneously with loss of CR1 in a concerted reaction in a rhesus monkey model. Clin Immunol Immunopathol 82:49-59. http://dx.doi.org/10.1006/clin.1996.4286.
62. Davies KA, Peters AM, Beynon HL, Walport MJ. 1992. Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies. J Clin Invest 90:2075-2083.
63. Emlen W, Carl V, Burdick G. 1992. Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes. Clin Exp Immunol 89:8-17.
64. Hepburn AL, Mason JC, Wang S, Shepherd CJ, Florey O, Haskard DO, Davies KA. 2006. Both Fcgamma and complement receptors mediate transfer of immune complexes from erythrocytes to human macrophages under physiological flow conditions in vitro. Clin Exp Immunol 146:133-145. http://dx.doi.org/10.1111/j.1365-2249.2006.03174.x.
65. Craig ML, Bankovich AJ, McElhenny JL, Taylor RP. 2000. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism. Arthritis Rheum 43:2265-2275. http://dx.doi.org/10.1002/1529-0131(200010)43:10<2265::AID-ANR14>3.0.CO;2-J.
66. Duval A, Helley D, Capron L, Youinou P, Renaudineau Y, Dubucquoi S, Fischer AM, Hachulla E. 2010. Endothelial dysfunction in systemic lupus patients with low disease activity: evaluation by quantification and characterization of circulating endothelial microparticles, role of antiendothelial cell antibodies. Rheumatology (Oxford) 49:1049-1055. http://dx.doi.org/10.1093/rheumatology/keq041.
67. Antwi-Baffour S, Kholia S, Aryee YK, Ansa-Addo EA, Stratton D, Lange S, Inal JM. 2010. Human plasma membrane-derived vesicles inhibit the phagocytosis of apoptotic cells-possible role in SLE. Biochem Biophys Res Commun 398:278-283. http://dx.doi.org/10.1016/j.bbrc.2010.06.079.
68. Sellam J, Proulle V, Jungel A, Ittah M, Miceli Richard C, Gottenberg JE, Toti F, Benessiano J, Gay S, Freyssinet JM, Mariette X. 2009. Increased levels of circulating microparticles in primary Sjogren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther 11:R156. http://dx.doi.org/10.1186/ar2833.
69. Pereira J, Alfaro G, Goycoolea M, Quiroga T, Ocqueteau M, Massardo L, Perez C, Saez C, Panes O, Matus V, Mezzano D. 2006. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state. Thromb Haemost 95:94-99. http://dx.doi.org/10.1160/TH05-05-0310.
70. Bhakdi S, Fassbender W, Hugo F, Carreno MP, Berstecher C, Malasit P, Kazatchkine MD. 1988. Relative inefficiency of terminal complement activation. J Immunol 141:3117-3122.
71. Willekens FL, Roerdinkholder-Stoelwinder B, Groenen-Dopp YA, Bos HJ, Bosman GJ, van den Bos AG, Verkleij AJ, Werre JM. 2003. Hemoglobin loss from erythrocytes in vivo results from spleen-facilitated vesiculation. Blood 101:747-751. http://dx.doi.org/10.1182/blood-2002-02-0500.
72. Almizraq R, Tchir JD, Holovati JL, Acker JP. 2013. Storage of red blood cells affects membrane composition, microvesiculation, and in vitro quality. Transfusion 53:2258-2267. http://dx.doi.org/10.1111/trf.12080.
73. Kozuma Y, Sawahata Y, Takei Y, Chiba S, Ninomiya H. 2011. Procoagulant properties of microparticles released from red blood cells in paroxysmal nocturnal haemoglobinuria. Br J Haematol 152:631-639. http://dx.doi.org/10.1111/j.1365-2141.2010.08505.x.
74. Willekens FL, Werre JM, Groenen-Dopp YA, Roerdinkholder-Stoelwinder B, de Pauw B, Bosman GJ. 2008. Erythrocyte vesiculation: a selfprotective mechanism? Br J Haematol 141:549-556. http://dx.doi.org/10.1111/j.1365-2141.2008.07055.x.
75. Moskovich O, Fishelson Z. 2007. Live cell imaging of outward and inward vesiculation induced by the complement C5b-9 complex. J Biol Chem 282:29977-29986. http://dx.doi.org/10.1074/jbc.M703742200.
76. Simak J, Gelderman MP. 2006. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 20:1-26. http://dx.doi.org/10.1016/j.tmrv.2005.08.001.
77. Shet AS, Aras O, Gupta K, Hass MJ, Rausch DJ, Saba N, Koopmeiners L, Key NS, Hebbel RP. 2003. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 102:2678-2683. http://dx.doi.org/10.1182/blood-2003-03-0693.
78. Alaarg A, Schiffelers RM, van Solinge WW, van Wijk R. 2013. Red blood cell vesiculation in hereditary hemolytic anemia. Front Physiol 4:365. http://dx.doi.org/10.3389/fphys.2013.00365.
79. Blum A. 2009. The possible role of red blood cell microvesicles in atherosclerosis. Eur J Intern Med 20:101-105. http://dx.doi.org/10.1016/j.ejim.2008.06.001.
80. Pankoui Mfonkeu JB, Gouado I, Fotso Kuate H, Zambou O, Amvam Zollo PH, Grau GE, Combes V. 2010. Elevated cell-specific microparticles are a biological marker for cerebral dysfunctions in human severe malaria. PLoS One 5:e13415. http://dx.doi.org/10.1371/journal.pone.0013415.
81. Sadallah S, Eken C, Schifferli JA. 2008. Erythrocyte-derived ectosomes have immunosuppressive properties. J Leukoc Biol 84:1316-1325. http://dx.doi.org/10.1189/jlb.0108013.
82. Mantel PY, Hoang AN, Goldowitz I, Potashnikova D, Hamza B, Vorobjev I, Ghiran I, Toner M, Irimia D, Ivanov AR, Barteneva N, Marti M. 2013. Malaria-infected erythrocyte-derived microvesicles mediate cellular communication within the parasite population and with the host immune system. Cell Host Microbe 13:521-534. http://dx.doi.org/10.1016/j.chom.2013.04.009.
83. Srikiatkhachorn A, Rothman AL, Gibbons RV, Sittisombut N, Malasit P, Ennis FA, Nimmannitya S, Kalayanarooj S. 2011. Dengue-how best to classify it. Clin Infect Dis 53:563-567. http://dx.doi.org/10.1093/cid/cir451.
84. Gan VC, Lye DC, Thein TL, Dimatatac F, Tan AS, Leo YS. 2013. Implications of discordance in World Health Organization 1997 and 2009 dengue classifications in adult dengue. PLoS One 8:e60946. http://dx.doi.org/10.1371/journal.pone.0060946.